Johnson & Johnson Postpones Medical Devices & Diagnostics Review

Johnson & Johnson Postpones Medical Devices & Diagnostics Review

PR Newswire

NEW BRUNSWICK, N.J., Oct. 30, 2012

NEW BRUNSWICK, N.J., Oct. 30, 2012  /PRNewswire/ -- Given the state of emergency in New Jersey due to Hurricane Sandy, Johnson & Johnson (NYSE: JNJ) announced that it will postpone the company's Medical Devices & Diagnostics business review for the investment community, which was scheduled for Thursday, Nov. 1^st.  The company made the postponement decision to ensure the safety of its employees and expected attendees in the aftermath of the storm.  A new date for the business review will be scheduled for early 2013.

About Johnson & Johnson

Caring for the world, one person at a time…inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 129,000 employees at more than 250 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

SOURCE Johnson & Johnson

Comments (0)

This discussion is now closed. We welcome comments on our articles for a limited period after their publication.